Fortress Biotech, Inc. (NASDAQ:FBIOP – Get Free Report) saw a large drop in short interest in the month of April. As of April 30th, there was short interest totaling 46 shares, a drop of 95.6% from the April 15th total of 1,041 shares. Based on an average daily trading volume, of 10,444 shares, the short-interest ratio is presently 0.0 days.
Fortress Biotech Trading Up 0.4%
NASDAQ FBIOP traded up $0.06 during trading on Monday, reaching $13.56. 17,863 shares of the company’s stock traded hands, compared to its average volume of 20,942. The company’s 50 day simple moving average is $13.67 and its two-hundred day simple moving average is $10.92. Fortress Biotech has a 12-month low of $5.99 and a 12-month high of $14.64.
Fortress Biotech Company Profile
Fortress Biotech, Inc (NASDAQ: FBIOP) is a biopharmaceutical company that acquires, develops and commercializes innovative therapeutics for the treatment of patients with serious diseases. Operating as a biotech accelerator, Fortress Biotech partners with experienced management teams to advance products from early-stage discovery through regulatory approval and commercial launch. Its diversified portfolio spans multiple therapeutic areas, including oncology, rare diseases, dermatology, ophthalmology and neuromuscular disorders.
The company’s business model centers on establishing and funding product-centric subsidiary companies, each focused on a specific drug candidate or therapy.
Read More
- Five stocks we like better than Fortress Biotech
- Before the Moon Base Gets Built, These 4 Companies Win
- Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases
- 3 Stocks That Win If Inflation Surprises to the Downside
- MercadoLibre Boldly Invests in Growth: Discount Deepens
Receive News & Ratings for Fortress Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fortress Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
